- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07354256
Acute Effects of Percussive Therapy
Acute Effects of Percussive Therapy Intensity on Agility, Vertical Jump Kinetics, and Neuromuscular Performance Across Morning and Evening Sessions in Trained Male Football Players
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Saudi Arabia
-
Riyadh, Saudi Arabia, Saudi Arabia, 12341
- Inonu University/ PNU
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male football players aged 18-25 years
- Possession of an active football license
- Minimum of 2 years of systematic football training experience
- Regular participation in football training at least three times per week
- Willingness and ability to attend both morning and evening testing sessions
- Ability to provide written informed consent
Exclusion Criteria:
- Presence of any acute or chronic musculoskeletal injury
- History of neurological disorders
- Any medical condition that could affect neuromuscular performance or limit safe participation
- Current illness, pain, or discomfort during the study period
- Inability to complete all experimental sessions or comply with study procedures
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: PASSIVE REST (Control)
Participants rested in a seated position for 5 minutes with no massage applied.
This condition served as the passive control to account for baseline performance and circadian variation.
|
Participants remained seated at rest for 5 minutes with no massage or device application.
This condition served as the passive control to account for baseline performance and circadian variation.
|
|
Experimental: Low-Intensity Percussive Massage (28 Hz)
Participants received low-intensity percussive massage using a handheld massage device at 28 Hz for a total duration of 5 minutes (2.5 minutes per leg), targeting the quadriceps, hamstrings, and gluteal muscles.
|
Percussive massage therapy was delivered using a handheld device (Hypervolt 2 Pro) applied bilaterally to the quadriceps, hamstrings, and gluteal muscles.
The total intervention duration was 5 minutes (2.5 minutes per leg).
Two intensity levels were used: low intensity at 28 Hz and moderate intensity at 35 Hz.
The device was applied using continuous longitudinal strokes at a controlled speed by a trained investigator immediately after a standardized warm-up.
|
|
Experimental: Moderate-Intensity Percussive Massage (35 Hz)
Participants received moderate-intensity percussive massage using a handheld massage device at 35 Hz for a total duration of 5 minutes (2.5 minutes per leg), targeting the quadriceps, hamstrings, and gluteal muscles.
|
Percussive massage therapy was delivered using a handheld device (Hypervolt 2 Pro) applied bilaterally to the quadriceps, hamstrings, and gluteal muscles.
The total intervention duration was 5 minutes (2.5 minutes per leg).
Two intensity levels were used: low intensity at 28 Hz and moderate intensity at 35 Hz.
The device was applied using continuous longitudinal strokes at a controlled speed by a trained investigator immediately after a standardized warm-up.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Agility Performance
Time Frame: Immediately post-intervention (morning and evening sessions)
|
Agility performance assessed using the T-Test T-Test: A cone configuration was set up forming a "T" shape (10 m forward, 5 m to the left, and 5 m to the right). The participants sprinted forward, shuffled laterally to the left and right, and backpedaled to the starting position. |
Immediately post-intervention (morning and evening sessions)
|
|
Countermovement Jump Height
Time Frame: Immediately post-intervention (morning and evening sessions)
|
Vertical jump height (cm) measured using the Countermovement Jump test via the My Jump Lab smartphone application. The highest value from three maximal trials was retained for analysis. Time Frame: |
Immediately post-intervention (morning and evening sessions)
|
|
Agility
Time Frame: Immediately post-intervention (morning and evening sessions)
|
Illinois Agility Test: Participants started from a prone position (chest on the floor), stood up, and sprinted through a slalom course marked by cones over a 10 m × 5 m area. The timing was recorded to the nearest 0.01 s using electronic timing gates (Brower Timing Systems, Draper, UT, USA). The participants performed two trials for each agility test, and the best performance was retained for statistical analysis. |
Immediately post-intervention (morning and evening sessions)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Vertical jump performance
Time Frame: Immediately post-intervention (morning and evening sessions)
|
Vertical jump performance parameters were assessed using the Countermovement Jump (CMJ) test via the My Jump Lab application (v.4.4.2, developed by Dr. Carlos Balsalobre).
This smartphone-based application uses high-speed video analysis to calculate jump variables and has been validated against gold-standard force platforms
|
Immediately post-intervention (morning and evening sessions)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PNU-9
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health Adult Subjects
-
ZHANG JiaqiRecruitingHealth Adult SubjectsChina
-
Nanjing Nutrabuilding Bio-tech Co., Ltd.Biofortis, Merieux NutriSciencesNot yet recruitingHealth Adult SubjectsUnited States
-
Nigde Omer Halisdemir UniversityActive, not recruiting
-
Shanghai Henlius BiotechNot yet recruitingHealth Adult SubjectsChina
-
Biotech Pharmaceutical Co., Ltd.Not yet recruiting
-
Genrix (Shanghai) Biopharmaceutical Co., Ltd.RecruitingHealth Adult SubjectsChina
-
Colgate PalmoliveCompletedHealth Adult SubjectsUnited States
-
Poznan University of Physical EducationCompletedHealth Adult SubjectsPoland
-
BiogenCelerion; Q2 SolutionsCompleted
-
Universidade Nova de LisboaNot yet recruitingImpact of a Wheat-based Fermented Beverage on Microbiota and Metabolic Health in Healthy IndividualsHealth Adult SubjectsPortugal
Clinical Trials on Passive Rest
-
Medipol UniversityNot yet recruiting
-
Universitas Muhammadiyah SurakartaCompletedHemodialysis | Anxiety | Chronic Kidney Disease | Spiritual Well-beingIndonesia
-
Joel TrinityNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingAging | Oxidative Stress | Skeletal Muscle | Vascular Endothelium | AntioxidantsUnited States
-
Cliniques universitaires Saint-Luc- Université...Unknown
-
University of VirginiaUniversity of Colorado, DenverRecruiting
-
The Affiliated Hospital of Qingdao UniversityNot yet recruiting
-
University Hospital, Clermont-FerrandLaboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques...CompletedAnorexia Nervosa | Constitutional LeannessFrance
-
Riphah International UniversityCompletedMusculoskeletal PainPakistan
-
AMCGRecruitingCoronary Artery DiseaseKorea, Republic of
-
Colorado State UniversityCompletedChronic InsomniaUnited States